News
Keep up to date on information that affects you
10.16.17
URGENT: Octapharma issues voluntary market withdrawal on 1 lot of Octagam® [Immune Globulin Intravenous (human)] 10% liquid preparation]
Octapharma USA Inc., is initiating a voluntary market withdrawal of one lot of Octagam® [Immune Globulin Intravenous (human)] 10% Liquid Preparation], in the interest of public safety. 
Read more >
10.11.17  URGENT: Important Drug Warning for Solu-Medrol® mg powder and solvent for solution in injection
Pfizer wants to inform all consumers of the following in regards to a contraindication for use of Solu-Medrol® 40 mg powder and solvent for solution
Read more >
09.21.17  URGENT UPDATE: Janssen issues recall of 2 additional lots of PROCRIT® (epoetin alfa) 1 mL Single-Dose, Preservative-free Solution
As a result of the ongoing quality investigation, Janssen Products, L.P., is expanding the voluntary recall of identified PROCRIT® (epoetin alfa) 1 mL Single-Dose, Preservative-free Solution to include two additional lots.
Read more >
09.20.17  Important Contrast Media Products Update
ASD Healthcare is starting the process of phasing out our selection of contrast media products.
Read more >
09.06.17  Shire issues important update to the prescribing information for Flexbumin® [Albumin (Human)]
Baxalta US Inc., an indirect wholly owned subsidiary of Shire plc (“Baxalta”) has issued an important update to the prescribing information for Flexbumin [Albumin (Human)]: a filter is no longer required during infusion. 
Read more >
09.06.17  URGENT: Genentech issues voluntary recall of 3 lots of Activase® (alteplase) vial – 100 mg
Genentech USA, Inc., is issuing a voluntary recall for three lots of Activase® (alteplase) vial – 100 mg. This recall has been initiated due to complaints of Sterile Water for Injection vials manufactured by Hospira, a Pfizer company.
Read more >
Displaying results 1-5 (of 28)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|